Skip to main content

Vazculep FDA Approval History

Last updated by Judith Stewart, BPharm on March 2, 2021.

FDA Approved: Yes (First approved June 27, 2014)
Brand name: Vazculep
Generic name: phenylephrine hydrochloride
Dosage form: Injection
Company: Flamel Technologies
Treatment for: Hypotension

Vazculep (phenylephrine hydrochloride) injection is an alpha-1 adrenergic receptor agonist indicated for the treatment of hypotension resulting primarily from vasodilation in the setting of anesthesia.

Development timeline for Vazculep

Jun 30, 2014Approval Flamel Technologies Announces FDA Approval of Vazculep

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.